15.92
-0.81%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Shijiazhuang Yiling Pharmaceutical Co
Its shares trade on Shenzhen under the ticker 002603.SZ. It has been listed since 28 July 2011. In the fiscal year to 31 December 2025, it reported revenue of CN¥7.83bn and net income of CN¥1.29bn. At that date it held total assets of CN¥13.67bn and shareholders' equity of CN¥10.99bn.
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in pharmaceutical manufacturing. The company is headquartered in Shijiazhuang, Hebei. The company went IPO on 2011-07-28. The firm mainly provides cardiovascular and cerebrovascular drugs and anti-cold drugs. The firm also provides food and beverage products. The firm distributes its products within domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 28 Jul 2011
- Employees
- 15,074
- Website
- yiling.cn ↗
Leadership
Pay as last reported
- Mr. Xiangjun WuChairman of the Board, General Manager, since 2010CN¥3.0m
- Mr. Yiling WuHonorary Chairman of the Board, since 2010CN¥163,300
- Mr. Chenguang LiFinance Director, Director, since 2010CN¥1.7m
- Ms. Qiulian ZhangDeputy General Manager, Director, since 2015CN¥1.9m
- Ms. Wei WangDeputy General ManagerCN¥840,000
- Mr. Keyuan ZhangDeputy General ManagerCN¥1.5m
- Mr. Xiaolin ZhouDeputy General ManagerCN¥1.2m
- Ms. Rui WuSecretary of the Board, Director, since 2010CN¥1.9m
- Mr. Weidong XuDirectorCN¥840,000
- Mr. Shaohua ZhaoDirector, since 2012CN¥840,000
- Mr. Zhenguo ChaiIndependent DirectorCN¥60,000
- Mr. Gang ChenIndependent DirectorCN¥120,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 67
- Environment
- 97
- Social
- 71
- Governance
- 33
- Women in the workforce
- 49.13%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Shijiazhuang Yiling Pharmaceutical employs 15,074 full-time employees for manufacturing.
- The company focuses on cardiovascular and cerebrovascular drugs and anti-cold drugs.
- Shijiazhuang Yiling Pharmaceutical distributes products domestically and internationally.
Weaknesses
- The company's business is limited to cardiovascular and cerebrovascular drugs and anti-cold drugs.
- Shijiazhuang Yiling Pharmaceutical has no overseas manufacturing facilities.
- The firm's product range includes food and beverage products which may dilute pharmaceutical focus.
Opportunities
- Shijiazhuang Yiling Pharmaceutical can expand into new markets within China's growing health care sector.
- The company can leverage its domestic market presence to increase international distribution.
- Shijiazhuang Yiling Pharmaceutical can develop new pharmaceutical products for emerging health needs.
Threats
- Shijiazhuang Yiling Pharmaceutical faces competition from other domestic pharmaceutical companies in China.
- The company's reliance on cardiovascular and cerebrovascular drugs may lead to market saturation.
- Shijiazhuang Yiling Pharmaceutical must comply with evolving Chinese pharmaceutical regulations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.